# Regulatory & Commercial Barrier Mapping

As an expert in global medical device regulation, assess the key regulatory and commercial hurdles for launching a novel IVD device in the top three markets (e.g., US, EU, China). Address:

- A side-by-side comparison of approval pathways (FDA 510(k), CE marking, NMPA).
- Typical timelines, costs, and risk factors for each region.
- Common commercial entry barriers (e.g., reimbursement, local distributor dynamics, clinician adoption).
- Strategic recommendations to mitigate each hurdle.

Answer in a **comparative table**, followed by **five prioritized strategic actions** to streamline market entry.
